What does CUSIP 55276N100 represent in this 13F holders report?

CUSIP 55276N100 is the security identifier for MRNA - MDRNA - Equities used to aggregate holder disclosures.

How many institutions held MRNA - MDRNA - Equities in Q1 2021?

1 institutional investor reported MRNA - MDRNA - Equities for Q1 2021. Use the holders table for investor-level position and value details.

MDRNA - Equities (MRNA)

CUSIP: 55276N100

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / Equities
Total 13F shares: 340
Total 13F value: $45,000
Share change: -31
SEC-reported price per share: $132.35
Number of holders: 1
Value change: -$4,103
Number of sells: 1

Security key

55276N100

Report period

Q1 2021

Institutions

Top holders

MRNA full security history Ownership snapshot Full 13F holder table Moderna, Inc. SEC filings Moderna, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MRNA - MDRNA - Equities (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BAILLIE GIFFORD & CO

Disclosed value leader

BAILLIE GIFFORD & CO

Comparable rows

0/15

Latest evidence

31 Dec 2020

13F Highest disclosed value: $2,539,903,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BAILLIE GIFFORD & CO has the largest disclosed position value at $2.54B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAILLIE GIFFORD & CO's linked filing trail.

Disclosed position value Top 5

BAILLIE GIFFORD & CO $2.54B

VANGUARD GROUP INC $2.44B

BlackRock Finance, Inc. $2.14B

FMR LLC $830.09M

STATE STREET CORP $629.4M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BAILLIE GIFFORD & CO	13F Company 13F	— denominator unverified	$2,539,903,000 24,312,271 shares	—	31 Dec 2020
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$2,441,657,000 23,371,855 shares	—	31 Dec 2020
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$2,139,202,000 20,476,714 shares	—	31 Dec 2020
FMR LLC	13F Company 13F	— denominator unverified	$830,087,000 7,945,698 shares	—	31 Dec 2020
STATE STREET CORP	13F Company 13F	— denominator unverified	$629,399,000 6,024,687 shares	—	31 Dec 2020
MORGAN STANLEY	13F Company 13F	— denominator unverified	$605,412,000 5,795,084 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

340

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q1 2021 value	Value change	Value Chg %